Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00477659 · ClinicalTrials.gov registry record · Phase 4
Neural Correlates In Mild Alzheimer's Disease
A Phase 4 study, sponsored by Eisai.
- Completed
- Registry status
- Phase 4
- Development phase
- 14
- Enrollment target
NCT00477659 is a Phase 4 study that has completed, run by Eisai. The registered enrollment target is 14 participants.
The verdict
NCT00477659, a Phase 4 study, has completed, sponsored by Eisai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 14 participants
- Enrollment target
Study Summary
The objective of this study was to identify neural correlates of cognitive improvement after 3 months of donepezil hydrochloride treatment using either or both of two functional magnetic resonance imaging (fMRI) measures - the functional Hippocampus Connectivity Index (HCI) and Cerebral Blood Flow (CBF) Perfusion; in the Medial Temporal Lobe (MTL) network in subjects in the early stage of Alzheimer's Disease (AD).
Interventions
- DRUG Donepezil hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2007-07-23 |
| Est. Completion | 2008-08-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00477659
The ClinicalTrials.gov registry entry for NCT00477659 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Eisai, which has 287 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Donepezil hydrochloride is the first listed.
NCT00477659 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00477659 about?
NCT00477659 is a clinical study titled "Neural Correlates In Mild Alzheimer's Disease". The objective of this study was to identify neural correlates of cognitive improvement after 3 months of donepezil hydrochloride treatment using either or both of two functional magnetic resonance imaging (fMRI) measures - the functional Hippocampus Connectivity Index (HCI) and Cerebral Blood Flow (...
What is the current status of trial NCT00477659?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 14 participants. The study started on 2007-07-23. Estimated completion is 2008-08-15.
What interventions are being tested in trial NCT00477659?
The interventions under investigation include: Donepezil hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00477659?
This trial is sponsored by Eisai, which has 287 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.